ROP vs DHR vs TMO vs VRSK

For growth investors, Roper Technologies, Inc.

(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Roper Technologies, Inc. (ROP) offers the better valuation at 24. 8x trailing P/E (16. 1x forward), making it the more compelling value choice. Analysts rate Roper Technologies, Inc. (ROP) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Roper Technologies, Inc.

(ROP) is the cheapest at 24. 8x versus Danaher Corporation at 34. 9x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 16. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Roper Technologies, Inc. wins at 1. 68x versus Danaher Corporation's 34. 35x — a reasonable growth-adjusted valuation.

Over the past 5 years, Thermo Fisher Scientific Inc.

(TMO) delivered a total return of +2. 8%, compared to -21. 1% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: TMO returned +229. 1% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Verisk Analytics, Inc.

(VRSK) is the lower-risk stock at -0. 04β versus Thermo Fisher Scientific Inc. 's 1. 10β — meaning TMO is approximately -3152% more volatile than VRSK relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Roper Technologies, Inc.

(ROP) is pulling ahead at 12. 3% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Thermo Fisher Scientific Inc. grew EPS 7. 3% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, ROP leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Verisk Analytics, Inc.

(VRSK) is the more profitable company, earning 29. 6% net margin versus 14. 7% for Danaher Corporation — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSK leads at 44. 6% versus 18. 2% for TMO. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Roper Technologies, Inc. (ROP) is the more undervalued stock at a PEG of 1. 68x versus Danaher Corporation's 34. 35x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 16. 1x forward P/E versus 22. 9x for Verisk Analytics, Inc. — 6. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.

All stocks in this comparison pay dividends.

Verisk Analytics, Inc. (VRSK) offers the highest yield at 1. 0%, versus 0. 4% for Thermo Fisher Scientific Inc. (TMO).

For long-horizon retirement investors, Verisk Analytics, Inc.

(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). Both have compounded well over 10 years (VRSK: +137. 1%, TMO: +229. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ROP (Industrials) and DHR (Healthcare) and TMO (Healthcare) and VRSK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

ROP, DHR, VRSK pay a dividend while TMO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.